• 1
    Wingo PA, Cardinez CJ, Landis SH, et al. Long term trends in cancer mortality in the United States. Cancer 2003; 97(suppl 12): 31333275.
  • 2
    Hurria A, Kris MG. Management of lung cancer in older adults. CA Cancer J Clin 2003; 53: 325341.
  • 3
    Balducci L, Beghe C. The application of the principles of geriatrics to the management of the older person with cancer. Crit Rev Hematol Oncol 2000; 35: 147154.
  • 4
    Balducci L, Yates G. General guidelines for the management of older patients with cancer. Oncology 2000; 14: 221227.
  • 5
    Borges M, Sculier JP, Paesmans M, et al. Prognostic factors for response to chemotherapy containing platinum derivatives in patients with unresectable non-small cell lung cancer. Lung Cancer 1996; 16: 2133.
  • 6
    Gridelli C, Perrone F, Gallo C, et al. Chemotherapy for elderly patients with advanced non-small cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized study. J Natl Cancer Inst 2003; 95: 362372.
  • 7
    Langer CJ, Manola J, Bernardo P, et al. Cisplatin-based therapy in the elderly patients with advanced non-small cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial. J Natl Cancer Inst 2002; 94: 173181.
  • 8
    Sledge GW, Neuberg D, Bernardo P, et al. Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as frontline chemotherapy for metastatic breast cancer. J Clin Oncol 2003; 21: 588593.
  • 9
    LeChevalier T. Results of the randomized International Adjuvant Lung Cancer Trial (IALT): cisplatin-based chemotherapy (CT) vs no CT in 1867 patients with resected non-small cell lung cancer [Abstract]. Proc Am Soc Clin Oncol 2003; 22: 2.